10 Best Under-the-Radar Stocks to Invest In
On July 6, Reuters reported that Morgan Stanley said weakening US semiconductor shares anticipated a broadening market recovery, with investors likely shifting to AI hyperscalers...
Posts Tagged ‘NASDAQ:MDGL’
12 Best High Short Interest Stocks With Highest Upside Potential
On May 29, Melissa Brown, Managing Director of Investment Decision Research, joined BNN Bloomberg to assess the health of the US economy.
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2026 Earnings Call Transcript
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2026 Earnings Call Transcript May 6, 2026Madrigal Pharmaceuticals, Inc. beats earnings expectations.
Madrigal Pharmaceuticals (MDGL) Surged on Strong Sales of Its Rezdiffra Drug
Janus Henderson Investors, an investment management company, released its “Forty Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
What Makes Madrigal Pharma (MDGL) One of the Shorted Biotech Stocks to Buy
On February 20, Bank of America Securities lowered the price target on Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) from $570 to $529, resulting in upside potential above 22%.
10 Most Shorted Biotech Stocks to Buy According to Hedge Funds
On February 5, J.P. Morgan shared its views on trends that are expected to define healthcare in 2026.
Madrigal Pharmaceuticals (MDGL) Reports Record 2025 Revenue Driven by Rezdiffra Success
Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the stocks with explosive growth potential.
10 Stocks With Explosive Growth Potential
On February 26, Darren Sissons, partner and portfolio manager at Campbell, Lee & Ross Investment Management, appeared on BNN Bloomberg to share his outlook on Global and Technology...
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q4 2025 Earnings Call Transcript
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q4 2025 Earnings Call Transcript February 19, 2026Madrigal Pharmaceuticals, Inc. misses on earnings expectations.
H.C. Wainwright Keeps Buy on Madrigal Pharmaceuticals (MDGL) on Strong Rezdiffra Uptake and F2/F3 MASH Patient Data
Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the high short interest stocks to buy right now. On November 21, H.C.
11 High Short Interest Stocks to Buy Right Now
On December 8, Bob Doll, Crossmark Global Investments CEO and CIO, joined CNBC’s ‘Squawk on the Street’ to discuss the latest market trends and his expectations for the ...
Madrigal Pharmaceuticals (MDGL) Surged Following the Strong Launch and Execution of New Drug
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Do You Believe in the Upside Potential of Madrigal Pharmaceuticals (MDGL)?
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q3 2025 Earnings Call Transcript
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q3 2025 Earnings Call Transcript November 4, 2025Madrigal Pharmaceuticals, Inc. misses on earnings expectations.
TD Cowen Sees Greater Upside in Madrigal (MDGL) Following Recent Rezdiffra Approval
Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the most shorted stocks right now.
10 Most Shorted Stocks Right Now
Short interest has become one of the most closely followed indicators in today’s market.
13 Best Mid Cap Growth Stocks to Buy According to Hedge Funds
On August 26, Courtney Garcia, Payne Capital Management senior wealth advisor, joined CNBC television for an interview to discuss whether investors should continue buying in the...
Do You Believe in the Upside Potential of Madrigal Pharmaceuticals (MDGL)?
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second-quarter 2025 investor letter.
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q2 2025 Earnings Call Transcript
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q2 2025 Earnings Call Transcript August 5, 2025Madrigal Pharmaceuticals, Inc. beats earnings expectations.
Madrigal Pharmaceuticals, Inc. (MDGL)’s Rezdiffra Hits 51% Liver Stiffness Reduction in Phase 3
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) is leading innovation in treating metabolic dysfunction-associated steatohepatitis (MASH), previously known as NASH.
Madrigal (MDGL) Secures $500M to Fuel MASH Pipeline Expansion
Madrigal Pharmaceuticals (NASDAQ:MDGL) is one of the best biotech stocks to buy according to billionaire Steve Cohen.
10 Best Biotech Stocks to Buy According to Billionaire Steve Cohen
Steve Cohen, whose success at SAC Capital made him one of the most successful hedge fund managers on Wall Street, is a worried man.
10 Most Undervalued Healthcare Stocks to Buy According to Analysts
The CEO of Pivotal Advisors, Tiffany McGhee, spoke on CNBC on June 27 on what investors should do in light of the current state of the market.
JMP Reaffirms Price Target for Madrigal Amid Rezdiffra Growth Potential
Madrigal Pharmaceuticals (NASDAQ:MDGL) ranks among the 30 stocks expected to beat the market by 20 percentage points this year.
30 Stocks Expected To Beat the Market By 20 Percentage Points This Year
The US stock market has gone through a turbulent journey this year. Following a correction in March and a lull in April, the S&P 500 recovered its losses in May and June.
Madrigal Pharmaceuticals Closer to EU Approval for First MASH Treatment, Rezdiffra
Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the best biotech stocks to invest in now.
13 Best Biotech Stocks To Invest In Now
In 2023, the global biotechnology market size was estimated at $1.55 trillion.
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential
Nicholas J. Pritzker is the chairman and co-founder of Tao Capital Partners, a San Francisco-based venture capital firm established in 2013.
Billionaire John Paulson’s 10 Stocks with Huge Upside Potential
John Alfred Paulson is an American billionaire hedge fund manager who founded Paulson & Co. in 1994.
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2025 Earnings Call Transcript
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2025 Earnings Call Transcript May 1, 2025Madrigal Pharmaceuticals, Inc. beats earnings expectations.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q4 2024 Earnings Call Transcript
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q4 2024 Earnings Call Transcript February 26, 2025Madrigal Pharmaceuticals, Inc. beats earnings expectations.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q3 2024 Earnings Call Transcript
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q3 2024 Earnings Call Transcript October 31, 2024Madrigal Pharmaceuticals, Inc. beats earnings expectations.
10 Biggest Stocks with Negative Beta to Consider
Beta is a measurement of market risk or volatility that indicates how much the price of a stock tends to fluctuate up and down compared to other stocks.
10 Best Guru Stocks To Buy Now
Due to the plethora of investment options such as equities, bonds, and mutual funds that are available today, picking the right set of vehicles to either preserve or grow money...
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q2 2024 Earnings Call Transcript
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q2 2024 Earnings Call Transcript August 7, 2024Madrigal Pharmaceuticals, Inc. beats earnings expectations.
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2024 Earnings Call Transcript
Madrigal Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-7.38 EPS, expectations were $-6.06.
Latest Insider Selling in April 2024: 10 Stocks to Watch
In this article, we will take a detailed look at Latest Insider Selling in April 2024: 10 Stocks to Watch. For a quick overview of the 5 such stocks, read our article Latest...
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
15 Best Strong Buy Stocks To Invest In
In this piece, we will take a look at the 15 best strong buy stocks to invest in.
11 Stocks Insiders and Billionaires Are Crazy About
In this article, we will take a detailed look at the 11 Stocks Insiders and Billionaires Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks Insiders...
11 Best Upside Stocks To Buy Right Now
In this piece, we will take a look at the 11 best upside stocks to buy right now.
Billionaire John Paulson’s Messy Divorce and Top 5 Stock Picks
In this article, we discuss billionaire John Paulson's Messy divorce and top 5 stock picks.
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
5 Biggest Stocks with Negative Beta
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) shares have gained about 200% over the past one year. In June Madrigal Pharmaceuticals, Inc.
10 Biotech Stocks with Biggest Upside
In this article, we discuss 12 biotech stocks with biggest upside.
5 Best Performing NASDAQ Stocks in 2022
CTI BioPharma Corp. (NASDAQ:CTIC) was incorporated in 1991 and is headquartered in Seattle, Washington.
5 Best Performing Biotech Stocks in 2022
Verona Pharma plc (NASDAQ:VRNA) is a London-based clinical stage biopharmaceutical company, focused on development and commercialization of therapies for the treatment of respiratory...
10 Best Stocks to Buy Now According to Billionaire Nicholas Pritzker’s Tao Capital
In this article, we discuss 10 best stocks to buy now according to billionaire Nicholas Pritzker's Tao Capital.
Hedge Fund Resource Center
